Search

Author/Creator Prokharau, A.

1. A DOUBLE‐BLIND, RANDOMIZED PHASE 3 STUDY TO COMPARE EFFICACY AND SAFETY OF CT‐P10 TO RITUXIMAB IN COMBINATION WITH CVP IN PATIENTS WITH ADVANCED‐STAGE FOLLICULAR LYMPHOMA. (June 2017)

Authors:
Buske, C.; Kim, W.; Kwak, L.; Coiffier, B.; Jurczak, W.; Sancho, J.M.; Zhavrid, E.; Kim, J.; Hernández Rivas, J.Á.; Prokharau, A.; Vasilica, M.; Nagarkar, R.; Osmanov, D.; Lee, S.; Lee, S.; Bae, Y.; Ogura, M.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
218
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Assessment of safety and tolerability of Herceptin subcutaneous administration in patients with HER2-positive early breast cancer: results of an open-label, randomized, multicenter, phase IIIB study. (March 2017)

Authors:
Talayeva, S.; Kaidarova, D.; Zhavrid, E.; Prokharau, A.; Antonenkova, N.; Shatkovskaya, O.; Manasheva, A.; Rutzhanova, Z.
Journal:
Breast
Issue:
Volume 32(2017)Supplement 1
Page Start:
S27
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search